SOPHiA GENETICS SA (SOPH) Financial Statements — Income, Balance Sheet, Cash Flow

Overview Financials Chart Business Summary Filings Ownership Valuation

Financial Statements — SOPH

Balance Sheet

(in millions USD)

Metric	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Cash & Equivalents	70.29	80.23	123.25	161.31	192.96
Inventory	6.35	5.87	6.48	5.16	5.73
Total Current Assets	99.08	99.41	148.05	196.26	282.86
Total Non-current Assets	63.95	55.90	58.11	47.58	37.32
Total Assets	163.03	155.31	206.16	243.84	320.17
Total Current Liabilities	50.53	26.80	35.62	26.81	28.60
Total Non-current Liabilities	65.36	32.02	19.09	16.90	16.17
Total Liabilities	115.89	58.82	54.71	43.71	44.77
Retained Earnings	(519.28)	(440.28)	(377.78)	(298.80)	(211.35)
Total Stockholder Equity	47.15	96.49	151.44	200.13	275.40

Income Statement

(in millions USD) (except per-share rows)

Metric	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	77.27	65.17	62.37	47.56	40.45
Cost of Revenue*	25.19	21.24	19.46	16.31	15.23
Gross Profit	52.08	43.94	42.91	31.25	25.22
Research & Development	34.22	34.37	36.97	35.37	26.58
Selling, General & Admin	52.56	46.95	53.30	55.82	41.51
Total Operating Expenses*	122.98	131.92	138.15	135.76	112.05
Operating Income	(70.91)	(66.57)	(74.83)	(87.82)	--
Interest Expense	4.55	1.91	0.59	0.64	0.66
Pretax Income	(77.49)	(61.27)	(78.49)	(87.58)	(73.51)
Tax Provision	1.51	1.22	0.49	(0.14)	0.17
Net Income	(79.00)	(62.49)	(78.98)	(87.45)	(73.67)
Basic EPS	(1.17)	(0.95)	(1.22)	(1.36)	--
Diluted EPS	(1.17)	(0.95)	(1.22)	(1.36)	--

* Derived from reported values

Cash Flow Statement

(in millions USD)

Metric	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Operating Cash Flow	(35.89)	(42.82)	(48.57)	(70.09)	(57.94)
Investing Cash Flow	(8.67)	(8.18)	8.32	41.97	(56.93)
Financing Cash Flow	30.18	11.59	(2.82)	(1.57)	237.77